A Phase I, Single Ascending Dose Study of Cimaglermin Alfa (Neuregulin 1β3) in Patients With Systolic Dysfunction and Heart Failure
暂无分享,去创建一个
J. Muldowney | D. Sawyer | L. Mendes | E. Brittain | D. Lenihan | R. Zolty | Sarah A. Anderson | C. Lenneman | Ping Zhao | J. Iaci | S. Frohwein | A. Eisen | A. Caggiano | S. Anderson